Ohcanbohtosat - M. Lelgemann
- Čájehuvvo 1 - 2 / 2
-
1
Intravitreal bevacizumab (Avastin) versus ranibizumab (Lucentis) for the treatment of age-related macular degeneration: a safety review Dahkki Christine Schmucker, Yoon K. Loke, Christoph Ehlken, Hansjürgen Agostini, L. L. Hansen, Gerd Antes, M. Lelgemann
Almmustuhtton 2010Revisão -
2
Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled t... Dahkki Dirk Eyding, M. Lelgemann, Ulrich Grouven, Martin Härter, Mandy Kromp, Thomas Kaiser, M Kerekeş, M Gerken, Beate Wieseler
Almmustuhtton 2010Revisão
Ohcanreaiddut:
Laktáseaddji fáttát
Adverse effect
Clinical trial
Cochrane Library
Confidence interval
Internal medicine
Law
MEDLINE
Medicine
Meta-analysis
Political science
Randomized controlled trial
Alternative medicine
Bevacizumab
Chemotherapy
Macular degeneration
Odds ratio
Ophthalmology
Pathology
Placebo
Psychiatry
Publication bias
Ranibizumab
Reboxetine
Receptor
Relative risk
Reuptake inhibitor
Serotonin